Tirzepatide Dosage Chart: How Your Doctor Titrates Your GLP-1 Dose

Tirzepatide Dosage

July 20, 2026

Book Appointment Today!

Nobody starts tirzepatide at the dose that actually drives weight loss. That surprises a lot of patients who assumed a prescription meant jumping straight to the “real” amount.

This chart applies whether you’re prescribed Zepbound for weight management or Mounjaro for type 2 diabetes; both use the same active drug, tirzepatide, and the same basic titration logic, even though the FDA-approved purpose differs between the two labels.

The Standard Titration Schedule

Tirzepatide (the active drug in Mounjaro and Zepbound) follows a stair-step dosing pattern, increasing roughly every four weeks:

Month	Weekly Dose	Purpose
Month 1	2.5 mg	Acclimation only, not intended to drive weight loss
Month 2	5 mg	First therapeutic-range dose
Month 3	7.5 mg	Continued escalation if tolerated
Month 4	10 mg	Common mid-range maintenance dose
Month 5	12.5 mg	Higher maintenance range
Month 6+	15 mg	Maximum approved dose

Not every patient climbs all the way to 15 mg, and that’s normal, not a failure. Many patients reach their goals and stabilize at 5 mg or 10 mg, and providers often hold a dose steady once weight loss and side effects both look reasonable, rather than automatically pushing to the ceiling.

What to Expect Physically at Each Stage

The 2.5 mg starting dose usually produces mild appetite reduction and, for some patients, very little noticeable effect at all; that’s expected, since this dose exists mainly to reduce the shock of starting.

By 5 mg, most patients notice a clearer drop in appetite and the first meaningful GI adjustment period, typically the most noticeable nausea of the entire titration process.

From 7.5 mg onward, appetite suppression tends to feel more consistent day to day, and weight loss becomes steadier and more predictable.

At 10 mg and above, most patients have settled into a routine, with side effects generally milder than what they experienced during the initial climb; the body has had months to adapt by then.

Why the Slow Climb Matters

Rushing this schedule is one of the most common reasons patients experience severe nausea or vomiting and quit treatment early.

Each dose increase essentially restarts a short adjustment period for your digestive system, and giving your body four weeks between steps gives it time to catch up before the next increase. Compressing that timeline, something that happens more often with unsupervised or online-only prescribing, dramatically raises the odds of a bad experience.

There’s also a metabolic reason for the gradual approach. Tirzepatide affects appetite-regulating hormones broadly, and a slow increase allows your body’s hunger and fullness signals to recalibrate gradually rather than getting overwhelmed all at once.

What If You're Not Losing Weight at Your Current Dose

A weight-loss plateau at a given dose isn’t automatically a sign something’s wrong. Some patients simply need more time before results show up; the body doesn’t always respond on a predictable weekly schedule.

If a genuine plateau lasts several weeks despite consistent use, a provider will typically check a few things before deciding to increase the dose:

Are you hitting your protein target?
Is your activity level consistent?
Have you had any recent life changes, travel, stress, illness that could be affecting results independent of the medication?

If everything checks out and the plateau persists, moving to the next dose step is usually the next move.

It’s worth noting that weight loss doesn’t move in a straight line. Water retention, hormonal cycles, and even how recently you ate before stepping on the scale can shift the number day to day.

What If Side Effects Are Too Strong

If nausea, vomiting, or GI symptoms are significant at a given dose, the answer isn’t always “push through it.” A provider may:

Hold the current dose for an extra few weeks before increasing, giving your body more time to adjust
Step back down to the previous dose temporarily if symptoms are severe, then re-attempt the increase more slowly
Adjust supporting habits: smaller meals, different food choices, better hydration, before changing the dose at all

This kind of real-time adjustment is exactly what separates a monitored titration schedule from a one-size-fits-all prescription mailed out with no follow-up. It’s also worth saying plainly: there’s no prize for reaching 15 mg faster than the schedule calls for.

Titration speed has no bearing on your final results; the medication works the same whether you take five months or eight months to reach maintenance dose, and rushing only raises the odds of a rough few weeks along the way.

Semaglutide Titration for Comparison

Since Wegovy and Ozempic follow a similar but distinct pattern, it’s worth seeing both side by side if you’re weighing your options:

Week	Semaglutide (Wegovy)	Tirzepatide (Zepbound)
1-4	0.25 mg	2.5 mg
5-8	0.5 mg	5 mg
9-12	1 mg	7.5 mg
13-16	1.7 mg	10 mg
17-20	2.4 mg (maintenance)	12.5 mg
21+	2.4 mg	15 mg (maintenance)

Semaglutide’s ladder has more, smaller increments early on, which is part of why some especially nausea-sensitive patients find it a gentler ramp-up, even though total time to reach a full maintenance dose ends up fairly similar between the two.

Missed Dose Guidelines

Missing a weekly dose happens. The general rule for tirzepatide: if it’s been less than four days since your scheduled dose, take it as soon as you remember and continue your regular weekly schedule from there.

If it’s been four or more days, skip the missed dose entirely and take your next dose on the regularly scheduled day; don’t double up to “catch up.” Missing more than two consecutive doses is worth a call to your provider, since restarting after a longer gap sometimes means dropping back to a lower dose rather than resuming where you left off.

How Titration Decisions Get Made at Windermere Medical Group

This is where a real clinical relationship shows its value. At each follow-up, providers at Windermere Medical Group review tolerability, weight trend, and lab markers before deciding whether to move up, hold steady, or step back a dose. This happens at any of our Georgia locations: Cumming, Canton, Alpharetta, Lawrenceville, Baldwin, and Gainesville.

Dr. Priya Bayyapureddy, MD, and the obesity-trained team don’t treat titration as a fixed calendar. It’s a decision made with the patient in the room, based on how that specific patient is actually responding, not a default script applied to everyone. That kind of adjustment is one of the clearest, most practical reasons physician-supervised treatment tends to outperform unsupervised prescribing on both comfort and results.

Maintenance Dosing and the Long Run

Once a patient reaches an effective, well-tolerated dose, treatment shifts into a maintenance phase, the same weekly dose continued over the following months, with periodic follow-ups and labs to confirm things are still on track.

GLP-1 therapy is generally considered chronic treatment. Most patients continue at a maintenance dose well beyond the point they reach their initial goal weight, since stopping tends to bring appetite back and often leads to some regain.

Decisions about eventually lowering the dose or tapering off are ones to make collaboratively with a provider, based on how stable your weight and health markers have been over time, not a decision to make alone once the scale hits a target number.

Final Thoughts

A tirzepatide dosage chart looks simple on paper: a straight line from 2.5 mg to 15 mg. In practice, the right pace depends entirely on how your body responds along the way, and that’s not something a fixed schedule can account for on its own. Regular follow-ups with a provider who’s actually watching your tolerability and progress, available at any Windermere Medical Group location in Georgia, make that adjustment possible in real time instead of guessing from a printed chart.

If you take one thing from this chart, let it be this: the number on the schedule is a guideline, not a deadline. Your body doesn’t know or care what month it is. It responds to how well it’s tolerating the current dose, how consistent your protein and hydration have been, and how much time it’s had to adjust. A provider paying attention to those signals, rather than a calendar alone, is what actually makes titration work the way it’s supposed to.